Total Payments
$233,931
2024 Payments
$102,332
Companies
19
Transactions
618
Medicare Patients
4,101
Medicare Billing
$230,522
Payment Breakdown by Category
Other$145,581 (62.2%)
Consulting$51,067 (21.8%)
Travel$24,594 (10.5%)
Food & Beverage$12,480 (5.3%)
Education$209.31 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $145,216 | 141 | 62.1% |
| Consulting Fee | $51,067 | 44 | 21.8% |
| Travel and Lodging | $24,594 | 158 | 10.5% |
| Food and Beverage | $12,480 | 269 | 5.3% |
| Honoraria | $365.00 | 1 | 0.2% |
| Education | $209.31 | 5 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $46,273 | 113 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $38,465 | 121 | $0 (2024) |
| GENZYME CORPORATION | $34,753 | 60 | $0 (2024) |
| ABBVIE INC. | $33,595 | 114 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $27,542 | 80 | $0 (2024) |
| Dermavant Sciences, Inc. | $20,514 | 36 | $0 (2024) |
| Eli Lilly and Company | $10,950 | 15 | $0 (2024) |
| Janssen Biotech, Inc. | $7,524 | 27 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $4,663 | 14 | $0 (2024) |
| Amgen Inc. | $3,079 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $102,332 | 272 | E.R. Squibb & Sons, L.L.C. ($32,733) |
| 2023 | $71,645 | 190 | Lilly USA, LLC ($17,501) |
| 2022 | $32,625 | 88 | Lilly USA, LLC ($9,307) |
| 2021 | $27,329 | 68 | Lilly USA, LLC ($8,734) |
All Payment Transactions
618 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $17.61 | General |
| Category: Immunology | ||||||
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.82 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: Dermatology | ||||||
| 12/10/2024 | Regeneron Healthcare Solutions, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,772.00 | General |
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $121.40 | General |
| Category: Immunology | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| 12/05/2024 | Regeneron Healthcare Solutions, Inc. | — | Travel and Lodging | In-kind items and services | $233.70 | General |
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $3.93 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Regeneron Healthcare Solutions, Inc. | — | Food and Beverage | In-kind items and services | $118.40 | General |
| 11/22/2024 | LEO Pharma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,275.00 | General |
| 11/21/2024 | Eli Lilly and Company | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| 11/21/2024 | Eli Lilly and Company | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,050.00 | General |
| 11/20/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Consulting Fee | Cash or cash equivalent | $1,750.00 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $128.23 | General |
| 11/18/2024 | Dermavant Sciences, Inc. | TAPINAROF (Drug) | Consulting Fee | Cash or cash equivalent | $1,575.00 | General |
| Category: DERMATOLOGY | ||||||
| 11/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $850.00 | General |
| Category: Immunology | ||||||
| 11/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $3,552.00 | General |
| Category: Immunology | ||||||
| 11/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $181.43 | General |
| Category: Immunology | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $1,717.50 | General |
| 11/12/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Dermatology | ||||||
| 11/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $249.70 | General |
| Category: Immunology | ||||||
| 11/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $133.87 | General |
| Category: Immunology | ||||||
| 11/08/2024 | LEO Pharma Inc. | — | Food and Beverage | In-kind items and services | $53.01 | General |
| 11/08/2024 | Celgene Corporation | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $49.96 | General |
| Category: Immunology | ||||||
| 11/08/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Travel and Lodging | Cash or cash equivalent | $48.58 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 994 | 1,332 | $317,206 | $55,225 |
| 2022 | 10 | 783 | 969 | $226,745 | $41,638 |
| 2021 | 11 | 1,230 | 1,742 | $399,605 | $69,108 |
| 2020 | 11 | 1,094 | 1,591 | $345,242 | $64,551 |
Total Patients
4,101
Total Services
5,634
Medicare Billing
$230,522
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 386 | 486 | $136,638 | $23,900 | 17.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 107 | 114 | $36,953 | $6,706 | 18.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 77 | 89 | $32,283 | $5,805 | 18.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 121 | 136 | $28,930 | $4,644 | 16.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 45 | 58 | $23,011 | $4,324 | 18.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 68 | 68 | $23,683 | $4,020 | 17.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 71 | 77 | $19,250 | $2,588 | 13.4% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 29 | 29 | $6,551 | $1,196 | 18.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 71 | 246 | $5,264 | $1,056 | 20.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 19 | 29 | $4,643 | $986.54 | 21.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 334 | 360 | $102,967 | $19,024 | 18.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 95 | 97 | $32,202 | $5,997 | 18.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 62 | 65 | $23,845 | $4,271 | 17.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 96 | 103 | $22,186 | $3,862 | 17.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 33 | 33 | $11,639 | $2,323 | 20.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 29 | 30 | $12,101 | $2,197 | 18.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 37 | 38 | $9,144 | $1,311 | 14.3% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 22 | 28 | $4,624 | $951.64 | 20.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 59 | 199 | $4,352 | $932.73 | 21.4% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 16 | 16 | $3,685 | $768.44 | 20.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 454 | 590 | $169,665 | $29,020 | 17.1% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 167 | 180 | $60,412 | $10,564 | 17.5% |
| 17000 | Destruction of skin growth | Office | 2021 | 164 | 196 | $41,402 | $6,594 | 15.9% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 88 | 102 | $37,374 | $6,132 | 16.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 81 | 81 | $28,593 | $5,056 | 17.7% |
About Eileen Cheever, PA-C
Eileen Cheever, PA-C is a Medical healthcare provider based in Leominster, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2008. The National Provider Identifier (NPI) number assigned to this provider is 1205099785.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Eileen Cheever, PA-C has received a total of $233,931 in payments from pharmaceutical and medical device companies, with $102,332 received in 2024. These payments were reported across 618 transactions from 19 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($145,216).
As a Medicare-enrolled provider, Cheever has provided services to 4,101 Medicare beneficiaries, totaling 5,634 services with total Medicare billing of $230,522. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical
- Other Specialties Medical
- Location Leominster, MA
- Active Since 07/06/2008
- Last Updated 01/30/2019
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1205099785
Products in Payments
- DUPIXENT (Biological) $51,311
- TALTZ (Drug) $32,897
- Sotyktu (Drug) $27,838
- SKYRIZI (Biological) $16,141
- VTAMA (Drug) $15,789
- RINVOQ (Biological) $15,247
- TREMFYA (Drug) $7,391
- TAPINAROF (Drug) $4,725
- Zoryve (Drug) $4,663
- Otezla (Drug) $3,079
- NULOJIX (Biological) $1,567
- ADBRY (Biological) $877.97
- HUMIRA (Biological) $564.99
- CIBINQO (Drug) $380.27
- COSENTYX (Drug) $162.06
- COSENTYX (Biological) $140.59
- REMICADE (Biological) $132.55
- Bimzelx (Biological) $107.27
- EUCRISA (Drug) $52.31
- Cimzia (Drug) $47.97
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.